Although these cell lines are both derived from cutaneous melanoma bearing BRAFV600E mutation, they are known to have different genetic statuses regarding PTEN, P53, CDKN2A, and CDK4 as reported by Villanueva and colleagues [43]. The gene discussed is CDKN2A; the disease is cutaneous melanoma.